Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

Breaking News: FDA warns that certain coronary imaging catheters are being removed from market

News You Need to Know Today
Breaking News: FDA warns that certain coronary imaging catheters are being removed from market
Friday, April 18, 2025
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

Breaking News

FDA warns that certain coronary imaging catheters are being removed from market over safety concerns

A catheter sheath detached during use and was left in the patient’s body. It was successfully removed, but the FDA said it is now evaluating the potential risk to others going forward. There is no official recall at this time.

READ MORE >
Conavi Medical’s Novasight Hybrid System catheter
Share on Twitter Share on Facebook Share on Linkedin

FDA warns that certain coronary imaging catheters are being removed from market over safety concerns

Share on Twitter Share on Facebook Share on Linkedin
Conavi Medical’s Novasight Hybrid System catheter
A catheter sheath detached during use and was left in the patient’s body. It was successfully removed, but the FDA said it is now evaluating the potential risk to others going forward. There is no official recall at this time.
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

Week in Review: 5/2
Pandemic watch: The biggest COVID-19 news in cardiology, all in one place
What high COVID-19 mortality among black patients says about CVD care in the US | Evolocumab & heart attack risk
Month in Review: 10 Trending Stories from April
Heart attack care during a pandemic | CMS allowing some providers to restart in-person care
Economics & Policy | April 2020
Pandemic watch: The biggest COVID-19 news in cardiology, all in one place

Pagination

    • First page « First
    • Previous page ‹‹
    • Page …342
    • Page 343
    • Page 344
    • Page 345
    • Current page 346
    • Page 347
    • Page 348
    • Page 349
    • Page 350 …
    • Next page ››
    • Last page Last »
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
 
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
 
Design by Adaptive Theme
Trimed Popup